Alzheimer's disease & dementia

Redefined Alzheimer's biology has implications for drug design

Despite the 25-year focus on the build-up in brain tissues of one protein, amyloid beta, as the purported origin of Alzheimer's disease (AD), a new study argues that it is likely triggered instead by the failure of a system ...

Alzheimer's disease & dementia

How Alzheimer's disease spreads throughout the brain – new study

Alzheimer's disease is a devastating brain illness that affects an estimated 47m people worldwide. It is the most common cause of dementia in the Western world. Despite this, there are currently no treatments that are effective ...

Parkinson's & Movement disorders

Cognitive status doesn't impact cortical A-beta, tau in Parkinson's

(HealthDay)—Patterns of cortical β-amyloid (Aβ) and tau are not different for patients with Parkinson's disease (PD) who are cognitively normal (PD-CN) or with mild cognitive impairment (MCI) and for healthy adults, according ...

Alzheimer's disease & dementia

PET tracer gauges effectiveness of promising Alzheimer's treatment

In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the first large-scale longitudinal imaging study to evaluate BACE1 inhibition with micro-PET in mouse models ...

Alzheimer's disease & dementia

New Alzheimer's animal model more closely mimics human disease

By injecting human Alzheimer's disease brain extracts of pathological tau protein (from postmortem donated tissue) into mice with different amounts of amyloid-β (Aβ) plaques in their brains, researchers from the Perelman ...

Alzheimer's disease & dementia

Alzheimer's Tau protein forms toxic complexes with cell membranes

The brains of patients with Alzheimer's disease contain characteristic tangles inside neurons. These tangles are formed when a protein called Tau aggregates into twisted fibrils. As a result, the neurons' transport systems ...

Alzheimer's disease & dementia

Researchers describe new biology of Alzheimer's disease

In a new study, researchers from Boston University School of Medicine (BUSM) describe a unique model for the biology of Alzheimer's disease (AD) which may lead to an entirely novel approach for treating the disease. The findings ...

page 27 from 40